They make the tools that helped Moderna make the Covid vaccine. Roared during the pandemic, then crashed in 2022, but is soaring now. Rumoured that Danaher could take this over.
Catalent is a American stock, trading under the symbol CTLT-N on the New York Stock Exchange (CTLT). It is usually referred to as NYSE:CTLT or CTLT-N
In the last year, 2 stock analysts published opinions about CTLT-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Catalent.
Catalent was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Catalent.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Catalent published on Stockchase.
On 2023-05-26, Catalent (CTLT-N) stock closed at a price of $37.12.
Danaher (he owns) or Illumina could buy CTLT, at least that's the talk. Until something happens, he won't buy this.